Wells, Adrian http://orcid.org/0000-0001-7713-1592
McNicol, Kirsten
Reeves, David
Salmon, Peter
Davies, Linda
Heagerty, Anthony
Doherty, Patrick
McPhillips, Rebecca
Anderson, Rebecca
Faija, Cintia
Capobianco, Lora
Morley, Helen
Gaffney, Hannah
Shields, Gemma
Fisher, Peter
Funding for this research was provided by:
Programme Grants for Applied Research (RP-PG-1211-20011)
Article History
Received: 18 October 2017
Accepted: 13 March 2018
First Online: 3 April 2018
Ethics approval and consent to participate
: The trial received full ethical approval from Preston Research Ethics Committee on 6 March 2015: REC Reference 14/NW/0163. The following sites have approved the trial: University Hospital of South Manchester NHS Foundation Trust; Central Manchester University Hospitals NHS Foundation Trust; East Cheshire NHS Trust; Stockport NHS Foundation Trust, and Pennine Acute Hospitals NHS Trust. The trial has obtained an International Standard Randomised Controlled Trial Number (ISRCTN reference: ISRCTN74643496). Any modifications to the protocol will be submitted for further ethical approval and approved changes will be documented on the ISRCTN registry. The trial will be conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki, 1996; the principles of Good Clinical Practice, and the Department of Health Research Governance Framework for Health and Social Care, 2005. Written informed consent will be obtained from all participants in the trial. Copies of the consent forms will be kept in the trial site files and the patients’ medical notes. Participants will be free to withdraw from the study at any time without giving a reason. All the information collected during this trial will be confidential and held in accordance with NHS Data Protection guidelines and Good Clinical Practice guidelines. Confidentiality will only be breached if patients disclose to us information which may indicate that there is a risk of harm to themselves or others.
: Not applicable.
: Professor Adrian Wells is the developer of metacognitive therapy and a co-director of the Metacognitive Therapy Institute.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.